View in EDS HTML Full Text PDF Full Text

CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors.

Saved in:
Bibliographic Details
Title: CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors.
Authors: Zouggari N; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland., Trugenberger C; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland., Du Bois V; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Wang W; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Rossetti GG; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland., Halazonetis TD; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland., Labidi-Galy I; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
Source: Frontiers in oncology [Front Oncol] 2025 Nov 19; Vol. 15, pp. 1626301. Date of Electronic Publication: 2025 Nov 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41347092
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zouggari+N%22">Zouggari N</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Trugenberger+C%22">Trugenberger C</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Du+Bois+V%22">Du Bois V</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rossetti+GG%22">Rossetti GG</searchLink>; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Halazonetis+TD%22">Halazonetis TD</searchLink>; Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Nov 19; Vol. 15, pp. 1626301. <i>Date of Electronic Publication: </i>2025 Nov 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41347092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1626301
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1626301
    Titles:
      – TitleFull: CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zouggari N
      – PersonEntity:
          Name:
            NameFull: Trugenberger C
      – PersonEntity:
          Name:
            NameFull: Du Bois V
      – PersonEntity:
          Name:
            NameFull: Wang W
      – PersonEntity:
          Name:
            NameFull: Rossetti GG
      – PersonEntity:
          Name:
            NameFull: Halazonetis TD
      – PersonEntity:
          Name:
            NameFull: Labidi-Galy I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 11
              Text: 2025 Nov 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1